- Home
- WABC vs TRVI Comparison
WABC vs TRVI Comparison
Compare WABC & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WABC
- TRVI
- Stock Information
- Founded
- WABC 1972
- TRVI 2011
- Country
- WABC United States
- TRVI United States
- Employees
- WABC N/A
- TRVI N/A
- Industry
- WABC Major Banks
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- WABC Finance
- TRVI Health Care
- Exchange
- WABC Nasdaq
- TRVI Nasdaq
- Market Cap
- WABC 1.3B
- TRVI 1.1B
- IPO Year
- WABC N/A
- TRVI 2019
- Fundamental
- Price
- WABC $47.50
- TRVI $9.77
- Analyst Decision
- WABC Hold
- TRVI Strong Buy
- Analyst Count
- WABC 2
- TRVI 9
- Target Price
- WABC $52.00
- TRVI $20.72
- AVG Volume (30 Days)
- WABC 165.5K
- TRVI 2.6M
- Earning Date
- WABC 10-16-2025
- TRVI 11-05-2025
- Dividend Yield
- WABC 3.86%
- TRVI N/A
- EPS Growth
- WABC N/A
- TRVI N/A
- EPS
- WABC 4.79
- TRVI N/A
- Revenue
- WABC $274,792,000.00
- TRVI N/A
- Revenue This Year
- WABC N/A
- TRVI N/A
- Revenue Next Year
- WABC N/A
- TRVI N/A
- P/E Ratio
- WABC $9.96
- TRVI N/A
- Revenue Growth
- WABC N/A
- TRVI N/A
- 52 Week Low
- WABC $42.00
- TRVI $2.36
- 52 Week High
- WABC $59.97
- TRVI $10.16
- Technical
- Relative Strength Index (RSI)
- WABC 37.62
- TRVI 64.17
- Support Level
- WABC $47.38
- TRVI $8.24
- Resistance Level
- WABC $50.08
- TRVI $8.65
- Average True Range (ATR)
- WABC 0.98
- TRVI 0.51
- MACD
- WABC -0.21
- TRVI 0.10
- Stochastic Oscillator
- WABC 5.96
- TRVI 75.35
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.